David Berman, MD, PhD, discusses signs of dose-dependent viral control and reduction in active HIV reservoir in Phase 1/2 STRIVE trial data.
David Berman, MD, PhD
Advertisement
Executive Vice President of Research and Development at Immunocore.
Articles by David Berman, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
The Potential Ramifications of Changing the MMR Vaccine Into 3 Separate Immunizations
2
Cascading Effects of Executive Order on Childhood Vaccines
3
Presidential Executive Order Changes Childhood Vaccine Schedule to Reflect Current Administration's Aims
4
Working Towards Hepatitis C Elimination
5